Chenxiang Biology (300138.SZ) has issued a profit forecast, expecting its net profit attributable to mother in the first half of the year to be between 2.02 billion and 2.32 billion yuan, a year-on-year increase of 102.33% to 132.38%.

Zh tng cijng APP xn, chngung shngw (300138.SZ) pl 2025 nin bnnin d yj ygo, gngs yj gush y shngsh gngs gdng de jnglr 2.02 y yun zh 2.32 y yun, tngb zngzhng 102.33% zh 132.38%; gush y shngsh gngs gdng kuch fi jngchngxng sny hu de jnglr 1.74 y yun zh 2.04 y yun, tngb zngzhng 117.40% zh 154.88% Zhtng Finance APP News, Chengguang Biology (300138.SZ) disclosed its semi-annual performance forecast for 2025, with the company expecting a net profit attributable to shareholders of listed companies of 2.02 billion to 2.32 billion yuan, a year-on-year increase of 102.33% to 132.38%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses is expected to be 1.74 billion to 2.04 billion yuan, a year-on-year increase of 117.40% to 154.88%.